Literature DB >> 6245153

Generalized viral illness caused by an intermediate strain of adenovirus (21/H21 + 35).

J C Hierholzer, A E Torrence, P F Wright.   

Abstract

Ten isolates of an antigenically intermediate strain of adenovirus were recovered from eight persons who presented febrile upper respiratory illness, pneumonia, or multisystem disease between November 1976 and August 1978. Six isolates were recovered from four members of an extended family in which the other nine members all had serologic evidence of infection; the other four isolates were epidemiologically unrelated. The isolates were placed in hemagglutination group IB on the basis of results of differential hemagglutination tests. All isolates were identified as adenovirus 21 by serum-neutralization tests and as types 21, 34, or 35 by hemagglutination-inhibition tests with reference rabbit and horse antisera. Conversely, rabbit antiserum to the intermediate strain had high titers of neutralizing antibody to adenovirus 21 and high titers of hemagglutination-inhibiting antibody to adenoviruses 21 and 35. The patients' serologic responses were similar. Thus, the isolates were typed as adenovirus 21/H21 + 35 and are the first such intermediate strains recorded.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6245153     DOI: 10.1093/infdis/141.3.281

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Molecular evolution of human species D adenoviruses.

Authors:  Christopher M Robinson; Donald Seto; Morris S Jones; David W Dyer; James Chodosh
Journal:  Infect Genet Evol       Date:  2011-05-05       Impact factor: 3.342

2.  Immunological and biochemical characterization of human adenoviruses from subgenus B. I. Antigenic relationships.

Authors:  R Wigand; N Sehn; J C Hierholzer; J C de Jong; T Adrian
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

3.  Antigenically intermediate human adenovirus strain associated with conjunctivitis.

Authors:  J C Hierholzer; F H Rodriguez
Journal:  J Clin Microbiol       Date:  1981-02       Impact factor: 5.948

4.  Molecular epidemiology of adenovirus type 21 in the Netherlands and the Federal Republic of Germany from 1960 to 1985.

Authors:  H G van der Avoort; T Adrian; R Wigand; A G Wermenbol; T P Zomerdijk; J C de Jong
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

5.  Antigenic relationships among the 47 human adenoviruses determined in reference horse antisera.

Authors:  J C Hierholzer; Y O Stone; J R Broderson
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

Review 6.  Adenoviruses in the immunocompromised host.

Authors:  J C Hierholzer
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

7.  Analysis of antigenically intermediate strains of subgenus B and D adenoviruses from AIDS patients.

Authors:  J C Hierholzer; T Adrian; L J Anderson; R Wigand; J W Gold
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

8.  Bacterial RecA Protein Promotes Adenoviral Recombination during In Vitro Infection.

Authors:  Jeong Yoon Lee; Ji Sun Lee; Emma C Materne; Rahul Rajala; Ashrafali M Ismail; Donald Seto; David W Dyer; Jaya Rajaiya; James Chodosh
Journal:  mSphere       Date:  2018-06-20       Impact factor: 4.389

Review 9.  Viral respiratory illnesses.

Authors:  L J Anderson; P A Patriarca; J C Hierholzer; G R Noble
Journal:  Med Clin North Am       Date:  1983-09       Impact factor: 5.456

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.